Comparable stake leader
GAGNON SECURITIES LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001628808.
Comparable stake leader
GAGNON SECURITIES LLC
Disclosed value leader
GAGNON SECURITIES LLC
Comparable rows
2/50
Latest evidence
30 Jun 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GAGNON SECURITIES LLC |
13D/G
13F
Neil Gagnon · Company
|
11%
Reported 13D/G
· 31 Dec 2024
|
$15,796,627
3,346,743 shares
|
$0 | 31 Dec 2024 |
| LETKO, BROSSEAU & ASSOCIATES INC |
13F
13D/G
Company
|
4.9%
Reported 13D/G
· 30 Sep 2024
|
$5,403,226
935,725 shares
|
— | 30 Jun 2026 |
| FIL Ltd |
13F
Company
|
—
denominator unverified
|
$15,760,496
2,370,000 shares
|
— | 30 Jun 2026 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
—
denominator unverified
|
$7,975,948
1,199,564 shares
|
— | 30 Jun 2026 |
| Timelo Investment Management Inc. |
13F
Company
|
—
denominator unverified
|
$7,414,531
1,114,967 shares
|
— | 30 Jun 2026 |
| Gagnon Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$6,398,537
962,186 shares
|
— | 30 Jun 2026 |
| Rosalind Advisors, Inc. |
13F
Company
|
—
denominator unverified
|
$5,506,985
828,118 shares
|
— | 30 Jun 2026 |
| Z3 Capital Partners, LLC |
13F
Company
|
—
denominator unverified
|
$5,459,258
820,941 shares
|
— | 30 Jun 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 21 Oct 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-1 of 1 reporting-owner rows connected to Profound Medical Corp.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Arun Swarup Menawat | CEO, Director | $2,776,930 | Filing P/S | 15 May 2025 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||